Me too. gets a little tough sometimes with this stock but nice to talk with logical, informed people when things go a little off track. thank you.
Great to see both you guys posting. Waiting out this wave of uncertainty for strong results in the future.
Horizon jacks up prices on arthritis drug
The most stunning price increase occurred in an arthritis drug made by Horizon Pharma (HZNP). The cost of each Vimovo 500-20 MG tablet went from $1.88 in 2013 to $23.86 this year, CNNMoney confirmed. That represents a surge of about 1,170%.
Horizon told CNNMoney that pricing is not -- nor has it ever been -- a key driver for its business. The company said 97% of all Vimovo patients pay $10 or less out of pocket (which still represents a 430% hike from the previous price).
The patients who pay the sticker price are those that don't have health insurance. In general, insurance companies negotiate a discounted rate.